Page last updated: 2024-11-03

propranolol and Wallerian Degeneration

propranolol has been researched along with Wallerian Degeneration in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Wallerian Degeneration: Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Romeo, HE1
Spinedi, E1
Esquifino, AI1
Estivariz, F1
Cardinali, DP1

Other Studies

1 other study available for propranolol and Wallerian Degeneration

ArticleYear
Anterograde nerve degeneration after superior cervical ganglionectomy coexists with a decrease in arginine vasopressin release in rats.
    Neuroendocrinology, 1991, Volume: 54, Issue:4

    Topics: Animals; Arginine Vasopressin; Ganglia, Sympathetic; Ganglionectomy; Male; Nerve Fibers; Pituitary G

1991